Basel
Switzerland
3
2019-05-16
3
2020-06-23
These are the the leading inventors for applications assigned to BALIOPHARM AG:
BALIOPHARM AG based in Basel, CH has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Monovalent anti-huTNFR1 antibodies, encoding nucleic acids thereof and methods of treatment thereof
#2 | 2015-10-01 ✅ Patent 10,590,202 granted on 2020-03-17Recombinant bispecific antibody binding to CD20 and CD95
#3 | 2013-09-26 ✅ Patent 8,859,739 granted on 2014-10-14Anti-huTNFR1 antibody and methods of use thereof for treatment
Also check out Baliopharm AG's (Basel, Switzerland) applicant profile with 3 patent applications submitted.
40379 ⎘